| Date & Time | 17 June 2026, 10:00-12:30 CEST |
|---|---|
| Address | Online, via Microsoft Teams |
EATRIS-CONNECT Annual General Meeting Day 3 – Public Session
As digital technologies, artificial intelligence and data-driven approaches continue to shape the future of translational medicine, meaningful patient engagement is more important than ever. This session on “Patient Engagement in the Digital Era” is taking place as part of the EATRIS-CONNECT Annual General Meeting. It will explore how patients can be involved not only as participants in research, but as active partners in shaping research priorities, study design, data use and digital health innovation.
The session will include expert talks on the role of AI in translational research, biomarker discovery, imaging and diagnostics, as well as a dedicated discussion on patient engagement in research. Patient stories and case examples will highlight practical approaches to co-creation, trust-building and the responsible use of patient-generated data.
The session is open to researchers, clinicians, patient representatives, research infrastructures, digital health professionals and anyone interested in strengthening patient involvement in digital health research.
Programme
10:00-10:10
Welcome and Setting the Scene
Florence Bietrix, EATRIS C&S and Marta Augucēviča, Riga Stradins University
10:10-10:35
Opening keynote: How AI Will Transform Translational Research in the Next 10 Years
Emīls Sjundjukovs, Longenesis
Key topics include patient engagement, citizen engagement, AI in drug discovery, digital twins in medicine, personalised medicine and AI in clinical trials.
10:35-11:00
From Biomarkers to Therapies: AI in Translational Research
Mohammadreza Azimi
This talk will explore AI for biomarker discovery, imaging and diagnostics, and the integration of AI into translational research pipelines.
11:00-11:15 Coffee break
11:15-11:30
Patients as Partners in Research: From Participation to Co-creation
Richard Buck, Pancreatic Cancer Patient Activist
11:30-12:00
Patients’ Stories
Rick Thompson & Zoe Alahouzou (Beacon), Patient engagement in Remedi4All drug repurposing platform, Marita Sandnes, Rare Disease Advocate, Board Member GRIN Europe Association, Norway, and Prof. Martin Kolísek (Head of the Laboratory of Proteomics and Mitochondriopathies, BioMed Martin, Slovkia)
This session will include patient stories and case examples from initiatives including REMEDi4ALL and rare disease research, with a focus on patient involvement in research design, patient-generated data, and building trust in the use of data and AI in research.
12:00-12:30
Interactive Polls & Discussion
Registration
Participation is free, but registration is required. Registered participants will receive the Microsoft Teams meeting link by email.
